Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > FNCH Finch Therapeutics > Detailed Quotes

FNCH Finch Therapeutics

1.670
+0.030+1.83%
Close 09/30 16:00 ET
1.6700.0000.00%
Post Mkt Price 09/30 18:00 ET
High
1.730
Open
1.620
Turnover
26.92K
Low
1.620
Pre Close
1.640
Volume
15.98K
Market Cap
79.64M
P/E(TTM)
Loss
52wk High
17.390
Shares
47.69M
P/E(Static)
Loss
52wk Low
1.580
Float Cap
37.65M
Bid/Ask %
0.00%
Historical High
22.500
Shs Float
22.55M
Volume Ratio
0.23
Historical Low
1.580
Dividend TTM
--
Div Yield TTM
--
P/B
0.50
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.07%
Amplitude
6.70%
Avg Price
1.684
Lot Size
1
Float Cap
37.65M
Bid/Ask %
0.00%
Historical High
22.500
Shs Float
22.55M
Volume Ratio
0.23
Historical Low
1.580
Dividend TTM
--
P/B
0.50
Dividend LFY
--
Turnover Ratio
0.07%
Amplitude
6.70%
Avg Price
1.684
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Somerville, MA.
CEO: Dr. Mark Smith, PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...